Back to Results
First PageMeta Content
GlaxoSmithKline / Dosage forms / Medical equipment / Bupropion / Syringe / Tablet / Time release technology / Timolol / Ranitidine / Chemistry / Pharmacology / Medicine


Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch January 1, 2011 Bulletin #127 ISSN 1923-077X
Add to Reading List

Document Date: 2014-06-26 15:57:54


Open Document

File Size: 49,98 KB

Share Result on Facebook

Company

NVR / Teva / 077X SASKATCHEWAN FORMULARY BULLETIN / /

Event

FDA Phase / /

Facility

Hospital Benefit List / /

IndustryTerm

ophthalmic solution / /

MedicalCondition

Ankylosing Spondylitis / Arthritis / MS / Psoriatic Arthritis / /

MedicalTreatment

counselling / /

Organization

1Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch Pharmacy Information Bulletin / Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch / Ministry of Health / /

/

Product

calcitriol / Potassium Chloride / 10mg/25mg / Topiramate / 600mg / Wellbutrin SR / 150mg / Ranitidine / SR tablet / Finasteride / 5mg / 150mg XL / Alfuzosin Novo-Alfuzosin PR 10mg / Topiramate Topiramate Topiramate Topiramate 25mg / glucagon / 1mg / Gabapentin / Zyban / DR tablet / 150mg SR / Remicade / Wellbutrin XL / 300mg / Omeprazole Novo-Omeprazole / 100mg SR / Champix tablet / Omeprazole / Lactulose / Apo-Enalapril/HCTZ tablet / Santyl / 300mg XL / GlucaGen / hydrochlorothiazide / Doribax / timolol maleate / Inclusion / Listing / /

ProgrammingLanguage

C * / /

ProvinceOrState

Saskatchewan / /

Technology

SAN / /

SocialTag